Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2025 Earnings Call Transcript May 12, 2025
Arcturus Therapeutics Holdings Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-1.58.
Operator: Good day. I would like to welcome everyone to Arcturus Therapeutics’ First Quarter 2025 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions]...
